The MGH-DFCI-BWH fellowship training program in neuro-oncology prepares academically oriented physicians to become leaders in clinical and laboratory investigation and clinical teaching. The program is a combined effort between Massachusetts General Hospital and Dana-Farber/Brigham and Women’s Cancer Center and is the only neuro-oncology program in the nation supported by a K12 training grant from the National Cancer Institute (NCI). Three to four trainees are accepted each year through the SF Match for one clinical year plus 1-2 optional research years. The program is accredited by the United Counsel for Neurologic Subspecialties (UCNS) and has accumulated more than 50 graduates since 1985, many of which are now faculty members of premier neuro-oncology programs across the United States.
Harvard Cancer Consortium (HCC) unites the cancer research efforts of the Harvard affiliated community including our program and is the largest NCI-designed Comprehensive Cancer Center in the nation. The HCC Neuro-Oncology Program is also only one of four recipients of an NCI-sponsored Specialized Program of Research Excellence (SPORE) grant for brain cancer research.